These regulations establish fees for the examination of applications or renewal of dealer’s licences for drugs and medical devices, setting a base fee of $4,510 per premises, with remission available if the applicant’s gross revenue is below 1% of the fee. Fees are increased annually by 2%, rounded up to the nearest dollar, starting April 1, 2012, and the regulations apply to private entities engaged in drug distribution, excluding public health facilities and government bodies.